Wonder
Sign up
Log in
Research Outline
Prepared for Onikepe | Delivered May 29, 2020
IBD COVID-19 Guidelines
Review your project details
Goals
To get a summary of IBD COVID-19 guidelines issued by organizations such as the American Gastroenterological Association (AGA) and the International Organisation for the Study of Inflammatory Bowel Disease (IOIBD).
View less
Early Findings
AGA Guidelines
Patients with IBD but not Infected by the Coronavirus
The AGA notes that available data suggests that people with IBD do not have a
higher probability
of getting SARS-CoV-2 compared to the general populations.
It recommends that people with IBD
continue on their current regimens
to avoid a relapse. The guidelines issued by the AGA also recommends that this group should
adopt the recommendations
provided to the general population such as social distancing and working from home.
The AGA guideline also notes that the IOIBD
supports the ongoing use
of infusion centers, as long as these centers take proactive actions such as having a COVID-19 screening protocol in place. This protocol should include: "
prescreening
of patients for exposure or symptoms of COVID-19, fever checks at the door, adequate spacing between chairs (minimum of 6 feet), masks and gloves used by providers and provided to patients, and adequate deep cleaning after patient departure."
The guideline also notes that IBD patients
should avoid
elective switching to injectable therapies or home infusions.
IOIBD Guidelines
The IOIBD recommends that gastroenterologists should
reduce the dose of prednisone
or stop it entirely to prevent infection from SARS-CoV-2. The prevailing votes also recommend that other IBD therapies be continued.
The group also voted to "
discontinue
the immune modulator in a patient who is known to be infected with SARS-CoV-2 or when a patient develops COVID-19." However, the group was uncertain if the dosage of immune modulators should be reduced or not.
The group also recommends that patients who had to stop their IBD medications because they tested positive for the coronavirus or because they had symptoms of COVID-19, should
continue their medications
if they develop no symptoms after two weeks in the case of the former, or wait till the symptoms have completely resolved in the case of the latter.
View less